Clinical trial
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
NCT00278564 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00278564 |
|---|---|
| Title | Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases |
| Official title | High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Transplantation in Patients With Refractory Idiopathic Inflammatory Myopathy Diseases: A Phase I Trial |
| Lead sponsor | Northwestern University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | MYOPATHY |
| Intervention type | Biological, Drug |
| Interventions | Hematopoietic stem cell transplantation, Cyclophosphamide, Mesna, ATG(rabbit), Methylprednisolone, G-CSF, Rituxan |
| Enrollment | 7 |
| Start date | Sep 1, 2005 |
| Primary completion | Jul 1, 2016 |
| Completion | Jul 1, 2016 |
| First posted | Jan 18, 2006 |
| Last update posted | Aug 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: